Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Fri, 14.03.2025       https://research-hub.de/companies/cyan AG

cyan AG reported strong preliminary 2024 results, with revenue increasing 50% yoy to EUR 7.1m, aligning with the upper half of guidance. Growth was driven by an 86% expansion in the subscriber base, while EBITDA losses narrowed significantly from EUR -4.5m to EUR -1.6m to -1.5m, supported by cost optimizations and the sale of the OSS/BSS business. For 2025, cyan targets EUR 8.4 - 9.2m in revenue and break-even EBITDA, supported by continued telecom expansion. While mwb research’s short-term growth expectations have been adjusted due to a mix of factors, such as slower new product ramp-up and customer onboarding delays in the telecom business, the analysts see stronger mid-to-long-term potential, partially offsetting downward revisions in their model. mwb research’s analysts reiterate their BUY rating with a revised price target of EUR 3.65 (previously EUR 3.85). The full update can be downloaded under https://www.research-hub.de/companies/cyan%20AG
Fri, 14.03.2025       https://research-hub.de/companies/Enapter AG

Enapter is expanding its product offering by integrating battery solutions from its joint venture with Wolong Group, which improves energy stability, optimizes hydrogen production, and enhances renewable energy utilization. Furthermore, the management has recently increased its stake in the company, signaling insider confidence, particularly in light of the challenging hydrogen market conditions. This move reflects management's commitment to the company’s long-term success, which mwb research’s analysts see as a reassuring signal. Despite current market challenges, Enapter’s solid order intake and low Price/Book ratio of 1.3x make its shares an attractive investment. The analysts maintain their Spec. BUY rating with an unchanged PT of EUR 7.00 based on cautious estimates. For firsthand insights from the CEO and CFO, register for the online roundtable March 19, here: https://research-hub.de/events/registration/2025-03-19-14-00/H2O-GR. The full update can be downloaded under https://www.research-hub.de/companies/Enapter%20AG
Fri, 14.03.2025       https://research-hub.de/companies/Circus SE

Circus SE has announced the appointment of Kasper Rørsted to its Board of Advisors, further strengthening its leadership as the company scales its autonomous food production systems. Rørsted, a highly accomplished executive with extensive experience in global business transformation, previously led Adidas (2016–2022) and Henkel (2008–2016) as CEO and held senior roles at Hewlett-Packard, Compaq, and Oracle. His strategic expertise in technology and operational excellence is expected to be instrumental in Circus’ global expansion. Today’s press release marks the second high-profile addition to Circus’ roster, following the appointment of Claus Holst-Gydesen as Co-CEO in February. First significant revenues expected in H2 should boost confidence in Circus’ ability to disrupt the global foodservice industry. mwb research’s analysts reiterate to BUY with a EUR 75.00 target price. For a recent first-hand update, please see the recording of the recent roundtable with the management here: https://researchhub.de/events/video/2025-02-05-13-30/CA1-GR. The full update can be downloaded under https://research-hub.de/companies/circus-se
Thu, 13.03.2025       https://research-hub.de/companies/Wacker Chemie AG

Wacker Chemie reported detailed Q4 and 2024 numbers that were in line with its preliminary release. Topline in Q4 and 2024 declined yoy and fell short of consensus, mainly due to weaker volumes, while 2024 EBITDA of EUR 763m (-7% yoy; Q4 EBITDA: +106% yoy, aided by one-offs) beat consensus of EUR 735m, with yoy decline was weighed down by high energy costs and scaled-back production. Despite these challenges, the chemicals business, including Silicones and Polymers, showed some resilience, while Biosolutions delivered impressive growth. Polysilicon, however, remained a drag, hit by weak solar-grade demand and Chinese oversupply. Looking ahead, mwb research’s analysts believe Wacker is well-positioned to navigate near-term headwinds through its cost-saving initiatives and strategic investments in high-margin specialty chemicals and semi polysilicon. The analysts expect 2025 to be a mixed but gradually improving year. Consequently, mwb research remains conservative in their estimates. With stock trading at attractive valuation levels, offering a favorable risk-reward profile, the analysts maintain their BUY rating with a revised PT of EUR 95.00. The full update can be downloaded under https://www.research-hub.de/companies/Wacker%20Chemie%20AG
Thu, 13.03.2025       https://research-hub.de/companies/Brenntag SE

Brenntag reported decent set of numbers in Q4 2024 with flat yoy sales in constant currencies (c.c.), and an operating (op.) gross profit growth of 1% yoy c.c., 1% ahead of consensus. However, volume-driven cost increases and inflationary pressure weighed on op. EBITA, dragging it down 9% yoy in c.c. to EUR 264m, 5% below consensus. In FY 2024, sales declined 3% yoy in c.c. to EUR 16.24bn and op. EBITA was down 13% yoy to EUR 1.1bn, ending at the lower end of its guidance range. Management expects depressed consumer sentiment, economic uncertainties, together with competition from Chinese imports, to prolong recovery. It guides for modest improvement in volumes and slightly better qoq pricing trends and op. EBITA to reach EUR 1.1bn-1.3bn (+9% yoy at the mid-point) in FY 25. On the strategy front, Brenntag continues to invest in cost containment programmes and is carrying out targeted segment disentanglement. These should help the company capitalize on emerging opportunities as markets regain momentum. mwb research’s analysts maintain their BUY rating with a new PT of EUR 79.00. The full update can be downloaded under https://www.research-hub.de/companies/Brenntag%20SE
Thu, 13.03.2025       https://research-hub.de/companies/Puma SE

Puma’s Q4 2024 results were in line with prelims, Q4 sales rising 16% yoy (+10% c.a.) to EUR 2.29bn, driven by broad-based growth across regions and channels. However, despite a 15% EBIT increase to EUR 109m, margins remained flat at 4.8%. FY24 saw moderate 3% revenue growth, but management’s cautious FY25 guidance—projecting low-to-mid single-digit sales growth and an EBIT range of EUR 520m-600m—fell short of consensus. Puma aims to restore profitability through its "nextlevel" program, focusing on product simplification and cost control, targeting an EBIT margin of 8.5% by 2027. With the stock down ~50% YTD, valuation appears attractive, prompting a reiterated BUY rating at a lower PT of EUR 35.00 (old: EUR 50.00) after mwb research’s analysts trimmed their EBIT trajectory to reflect a slower recovery. The full update can be downloaded www.research-hub.de/companies/research/Puma%20SE
Thu, 13.03.2025       https://research-hub.de/companies/Rheinmetall AG

Rheinmetall’s FY24 earnings call confirmed its strong position as a key player in the defense sector, surpassing expectations. The company’s strategic focus on the "3 Ps" - Products, Price, and Politics - reinforces mwb research’s bullish outlook. Products: Rheinmetall is at the forefront of European defense needs, securing high-profile meetings and contracts while demonstrating unmatched production efficiency. Price: Its high vertical integration delivers a clear cost advantage over competitors, particularly in ammunition and tank production. Politics: With rising defense budgets and increasing equipment expenditures, Rheinmetall’s market share is set to grow significantly, supporting long term revenue projections in a range between EUR 34bn to EUR 70bn by 2032. Given these factors, mwb research’s analysts raise their price target to EUR 1,990 (previously 1,280) and maintain their BUY rating ahead of Germany’s crucial defense budget decision next week. The full update can be downloaded under https://www.research-hub.de/companies/Rheinmetall%20AG
Wed, 12.03.2025       https://research-hub.de/companies/Redcare Pharmacy NV

Redcare Pharmacy’s FY24 results were largely in line with preliminary figures, with sales up 32% yoy to EUR 2.37bn, reaching the lower end of guidance. Q4 revenue grew 27% yoy to EUR 675m, fueled by strong Rx (+37% yoy) and non-Rx (+22% yoy) sales. However, adjusted EBITDA fell 38% yoy to EUR 33m (1.4% margin) due to higher e-Rx marketing spend and a weaker flu season, leading to a Q4 EUR 4.9m EBITDA loss. e-Rx adoption in Germany continues to accelerate, driving Rx sales up 142% yoy in the country. RDC guides for 2025 sales growth of over 25%, with German Rx sales doubling to EUR 500m. The adjusted EBITDA margin is expected at 2-2.5%. mwb research’s analysts revise their estimates for a more measured profitability outlook, maintaining their EUR 144.00 PT but downgrading to HOLD (before: BUY). The full update can be downloaded under https://www.research-hub.de/companies/Redcare%20Pharmacy%20N.V.
Wed, 12.03.2025       https://research-hub.de/companies/GEA Group AG

GEA reported strong Q4 2024 results, with order intake and sales surpassing consensus by 17% and 3%, respectively. Order intake grew organically by 29.3% yoy on good traction in large orders (7 won in the >EUR15m range) and also benefitted from a lower comparable base. Revenues were up 9% yoy organically, led by its service business (+19% yoy). Adjusted (adj.) EBITDA came in higher by 15% yoy at EUR 239m, with the margin improving +1.4ppt yoy to 15.9% on better gross margins. FY 2024 org. sales were up 4% yoy and adj. EBITDA was higher by 8% yoy (margin of 15.4%; +1ppt yoy). For FY 2025, management guides for org. revenue growth of 1%-4% yoy and an adj. EBITDA margin of 15.6%-16.0%, with a yoy expansion of 40bps expected at the mid-point, which appears realistic. GEA achieved its FY 2026 targets two years in advance; however, its FY 2030 goals appear highly ambitious in the context of current macroeconomic risks. mwb research’s analysts reiterate their HOLD rating on GEA at a higher PT of EUR 55.00 (old: EUR 50.00) after incorporating the latest results. The full update can be downloaded under https://www.research-hub.de/companies/GEA%20Group%20AG
Wed, 12.03.2025       https://research-hub.de/companies/Rheinmetall AG

Rheinmetall delivered strong FY 2024 results, driven by surging defense demand and record profitability. The order backlog hit an all-time high and could have been even higher, as key projects will be booked in Q1 2025, potentially pushing it to EUR 67bn. Defense margins remain strong with further upside, and while some analysts expected slightly higher revenue, the company is still in its ramp-up phase, with major growth ahead. With CAPEX at 9% of sales - far exceeding peers - Rheinmetall is clearly positioning itself to secure a dominant share of the potential EUR 200bn German special fund. FY 2024 met expectations, but the real focus is on long-term expansion. Its strong product portfolio and aggressive investments make it well positioned to be the clear winner of the defense cycle. mwb research’s analysts maintain their EUR 1,280 price target and reiterate their BUY rating. The full update can be downloaded under https://www.research-hub.de/companies/Rheinmetall%20AG

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Monday, 14.07.2025, Calendar Week 29, 195th day of the year, 170 days remaining until EoY.